J. Barben (St-Gallen, Switzerland), D. Hartl (Tuebingen, Germany), F. Ratjen (Toronto, Canada), A. Bush (London, United Kingdom)
LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin
T. Scott-Ward, J. Shute (Portsmouth, United Kingdom)
|  |
LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
A. Yacob, J. Zirbes, C. Dunn, R. Zamanian, R. Bland, M. Rabinovitch, M. Nicolls, C. Milla (Palo Alto, United States Of America)
| |
Single nucleotide polymorphims 1540G/A, 2694T/G and 4521G/A of CFTR gene and their association with cystic fibrosis phenotype
L. Minarowski, A. Minarowska, D. Sands, O. Kowalczuk, L. Chyczewski, E. Chyczewska, E. Chyczewska (Bialystok, Warsaw, Poland)
| |
Connexin 37 and connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF)
M. Ludwig, O. Eickmeier, C. Smaczny, F. Schreiner, W. Dubois, D. NGampolo, R. Schubert, S. Zielen, R. Ganschow, S. Schmitt-Grohé (Bonn, Frankfurt, Germany)
| |
Polymorphisms in NOS-1 and NOS-3 genes may influence the cystic fibrosis severity?
F. Marson, C. Bertuzzo, A. Ribeiro, J. Ribeiro (Campinas, Brazil)
| |
L-Arginine metabolism in airways of children with primary ciliary dyskinesia (PCD) or cystic fibrosis (CF)
H. Grasemann, N. McDonald, S. Dell, F. Ratjen (Toronto, Canada)
| |
Decreased expression of HLA-DQ and -DR on blood monocytes, sputum macrophages and monocyte-derived macrophages in patients with cystic fibrosis
T. P. Hofer, M. Frankenberger, I. Heimbeck, D. Burggraf, M. Wjst, A. K. A. Wright, M. Kerscher, S. Nährig, R. M. Huber, R. Fischer, L. Ziegler-Heitbrock (Gauting, Munich, Germany; Leicester, United Kingdom)
|  |
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
J. S. Elborn, K. O'Neill, E. Johnston, J. M. Bradley, S. Rowan, A. Reid, M. M. Tunney (Belfast, United Kingdom)
| |
Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF)
H. Grasemann, V. Waters, N. McDonald, Y. Yau, S. Dell, F. Ratjen (Toronto, Canada)
| |
Inflammatory biomarkers in urine of cystic fibrosis patients
G. Parekh, M. Tunney, E. Vallières, S. McGrath, L. McIlreavey, E. Johnston, D. Downey, K. Woolston, P. Davis, S. Elborn (Bedford, Belfast, United Kingdom)
| |
Adaptation of prevotella during acute infectious pulmonary exacerbation
S. Elborn, D. Mooney, M. Tunney, S. McGrath, L. McIlreavey, E. Johnston, T. Matier (Belfast, United Kingdom)
| |
Rhinovirus infections in the upper and lower airways of young Australian children with cystic fibrosis
S. Stelzer-Braid, R. D'Cunha, C. Willenborg, M. Doumit, Y. Belessis, E. Tovey, A. Jaffe, W. Rawlinson (Sydney, Australia)
| |
Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds
A. Abdul Wahab, S. J. Taj-Aldeen, E. Ibrahim, S. Hussain, R. Mohammed, I. Ahmed, M. Abu-Madi (Doha, Qatar)
| |
Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis- and COPD patients
P. Morán Losada, B. Tümmler, L. Wiehlmann, P. Chouvarine (Hannover, Germany)
| |